Virtus ETF Advisers LLC Codexis, Inc. Transaction History

Virtus ETF Advisers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.81 - $6.76 $26,540 - $47,090	-6,966 Reduced 27.75%	18,136 $75,000
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $56,755 - $91,129	13,323 Added 113.11%	25,102 $116,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $533 - $1,131	88 Added 0.75%	11,779 $71,000
Q2 2022 Aug 12, 2022	BUY	$8.35 - $21.89 $55,677 - $145,962	6,668 Added 132.75%	11,691 $122,000
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $4,955 - $9,323	-292 Reduced 5.49%	5,023 $104,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $41.78 $116,525 - $190,099	-4,550 Reduced 46.12%	5,315 $166,000
Q3 2021 Nov 15, 2021	SELL	$19.65 - $27.99 $10,218 - $14,554	-520 Reduced 5.01%	9,865 $229,000
Q2 2021 Aug 10, 2021	SELL	$17.48 - $25.46 $97,258 - $141,659	-5,564 Reduced 34.89%	10,385 $235,000
Q1 2021 May 17, 2021	BUY	$18.08 - $28.8 $5,243 - $8,352	290 Added 1.85%	15,949 $365,000
Q4 2020 Feb 12, 2021	BUY	$11.7 - $23.41 $183,210 - $366,577	15,659 New	15,659 $342,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.